Clofazimine is the drug of choice for the treatment of leprosy

Clofazimine is the drug of choice for the treatment of leprosy: Clofazimine was launched as a leprosy treatment drug by the Swiss Ciba Geigy Company in 1969, and in 1986, Clofazimine was approved for marketing by the US FDA. At this stage, Clofazimine is mainly used as the drug of choice for the treatment of neoplastic leprosy, especially for the treatment of infections caused by strains resistant to sulfone drugs.

Clofazimine is a drug used to treat neoplastic leprosy. Used in combination with dapoxone, it can consolidate the efficacy of clofazimine. Clofazimine can also be used to treat erythematous nodular leprosy. Clofazimine is a commonly used capsule, which contains brown-red or reddish-brown suspension oily liquid. The main component is clofazimine. Clofazimine can be used for the treatment of leprosy and can also be used as the first-choice treatment drug. If necessary, it can be used in combination with other drugs, such as rifampicin or ethionicotinamide, which can effectively treat sulfone-resistant bacterial infections. Clofazimine has significant efficacy.

Clofazimine can treat various types of dapsone-resistant leprosy. It is taken orally, 50 to 100 mg once a day, in combination with one or several other anti-leprosy drugs. Special attention should be paid to the dosage of the drug when treating adults and children with Clofazimine. The maximum daily dose for adults treated with Clofazimine should not exceed 300 mg. Therapeutic dosage of Clofazimine in children has not been established. Clofazimine is used to treat other skin diseases: 100 to 400 mg orally per day, and gradually reduce the dosage after the condition is controlled. Different patients, different ages, and different symptoms will affect the dosage of Clofazimine. The use of this drug must be fully considered based on the advice of your doctor. After two weeks of treatment with Clofazimine, patients will develop red staining of the skin and mucous membranes, which appears pink and brown. After stopping the drug for 2 months, the patient's pigment gradually decreased and gradually disappeared within about 1-2 years.

The above is the introduction about Clofazimine. If patients have other questions about Clofazimine (such as drug prices, purchase channels, etc.), they can consult the medical companion travel service.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: